Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice

Vaccine X(2025)10.1016/j.jvacx.2025.100699Source: DataRank Database

Mincle receptor agonist UM-1098 and TLR4 agonist INI-2002 combination adjuvant enhances Th1 responses and provides protection against Mycobacterium tuberculosis challenge in mice is a research paper published in Vaccine X (2025). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 0.00)OA: goldTopics (18)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (9)

Grace C. Jones,Mushtaq Ahmed ORCID,Vibha Taneja ORCID,Alexander Riffey ORCID,Walid Abdelwahab ORCID

Live enrichment

PubMed:42598270 OpenAlex:https://openalex.org/W4413043869

National Institute of Allergy and Infectious Diseases

Grant: HHSN272201400050C

National Institute of Allergy and Infectious Diseases

Grant: U01AI160406

National Institute of Allergy and Infectious Diseases

Grant: 75N93023C00047

FWCI

0.00

Citation Percentile

0.1%

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.jvacx.2025.100699

publisherhttps://doi.org/10.1016/j.jvacx.2025.100699

publisherhttps://api.elsevier.com/content/article/PII:S2590136225000932?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2590136225000932?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/42598270

Fields of Study

Immune Response and InflammationTuberculosis Research and EpidemiologyPediatric health and respiratory diseases

Keywords

AgonistMycobacterium tuberculosisAdjuvantTLR4TuberculosisMedicineReceptorPharmacologyImmunologyInternal medicinePathologysubunit vaccineMincleTh1/th17M72

Sustainable Development Goals

SDG 0: Good health and well-being